131 related articles for article (PubMed ID: 2578898)
1. Changes in pulmonary function during and after bleomycin treatment in patients with testicular carcinoma.
van Barneveld PW; Veenstra G; Sleijfer DT; van der Mark TW; Mulder NH; Schraffordt Koops H; Sluiter HJ; Peset R
Cancer Chemother Pharmacol; 1985; 14(2):168-71. PubMed ID: 2578898
[TBL] [Abstract][Full Text] [Related]
2. Decrease in pulmonary function during bleomycin-containing combination chemotherapy for testicular cancer: not only a bleomycin effect.
Sleijfer S; van der Mark TW; Schraffordt Koops H; Mulder NH
Br J Cancer; 1995 Jan; 71(1):120-3. PubMed ID: 7529523
[TBL] [Abstract][Full Text] [Related]
3. Bleomycin-induced changes in the carbon monoxide transfer factor of the lungs and its components.
Luursema PB; Star-Kroesen MA; van der Mark TW; Sleyfer DT; Koops HS; Peset R
Am Rev Respir Dis; 1983 Nov; 128(5):880-3. PubMed ID: 6195947
[TBL] [Abstract][Full Text] [Related]
4. A reduction in pulmonary capillary blood volume in patients with disseminated testicular carcinoma.
van Barneveld PW; Mulder NH; Sleijfer DT; van der Mark TW; Schraffordt Koops H; Sluiter HJ; Peset R
Eur J Cancer Clin Oncol; 1985 Jun; 21(6):675-9. PubMed ID: 2410279
[TBL] [Abstract][Full Text] [Related]
5. Natural course of bleomycin-induced pneumonitis. A follow-up study.
Van Barneveld PW; Sleijfer DT; van der Mark TW; Mulder NH; Koops HS; Sluiter HJ; Peset R
Am Rev Respir Dis; 1987 Jan; 135(1):48-51. PubMed ID: 2432813
[TBL] [Abstract][Full Text] [Related]
6. Study of functional and biochemical indicators of subclinical lung damage in bleomycin-treated patients.
Villani F; Bacchella L; Bulgheroni A; Pizzini L; Galimberti M; Aprile C; Luisetti M
Respir Med; 1992 Jul; 86(4):327-33. PubMed ID: 1280368
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors for bleomycin-induced pneumonitis.
Van Barneveld PW; van der Mark TW; Sleijfer DT; Mulder NH; Koops HS; Sluiter HJ; Peset R
Am Rev Respir Dis; 1984 Dec; 130(6):1078-81. PubMed ID: 6210002
[TBL] [Abstract][Full Text] [Related]
8. Enhanced effects of bleomycin on pulmonary function disturbances in patients with decreased renal function due to cisplatin.
Sleijfer S; van der Mark TW; Schraffordt Koops H; Mulder NH
Eur J Cancer; 1996 Mar; 32A(3):550-2. PubMed ID: 8814706
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and functional markers of lung damage after bleomycin treatment.
Villani F; Galimberti M; Barbieri A; Luisetti M; Bacchella L; Aprile C
Monaldi Arch Chest Dis; 1995 May; 50(3):183-6. PubMed ID: 7545055
[TBL] [Abstract][Full Text] [Related]
10. Bleomycin-Induced Pulmonary Changes on Restaging Computed Tomography Scans in Two Thirds of Testicular Cancer Patients Show No Correlation With Fibrosis Markers.
den Hollander MW; Westerink ND; Lubberts S; Bongaerts AH; Wolf RF; Altena R; Nuver J; Oosting SF; de Vries EG; Walenkamp AM; Meijer C; Gietema JA
Oncologist; 2016 Aug; 21(8):995-1001. PubMed ID: 27328932
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary Function in Patients With Germ Cell Cancer Treated With Bleomycin, Etoposide, and Cisplatin.
Lauritsen J; Kier MG; Bandak M; Mortensen MS; Thomsen FB; Mortensen J; Daugaard G
J Clin Oncol; 2016 May; 34(13):1492-9. PubMed ID: 26903578
[TBL] [Abstract][Full Text] [Related]
12. Role of pulmonary function tests in the prevention of bleomycin pulmonary toxicity during chemotherapy for metastatic testicular teratoma.
Lucraft HH; Wilkinson PM; Stretton TB; Read G
Eur J Cancer Clin Oncol; 1982 Feb; 18(2):133-9. PubMed ID: 6178590
[TBL] [Abstract][Full Text] [Related]
13. Role of single-breath carbon monoxide-diffusing capacity in monitoring the pulmonary effects of bleomycin in germ cell tumor patients.
Comis RL; Kuppinger MS; Ginsberg SJ; Crooke ST; Gilbert R; Auchincloss JH; Prestayko AW
Cancer Res; 1979 Dec; 39(12):5076-80. PubMed ID: 91430
[TBL] [Abstract][Full Text] [Related]
14. Role of carbon monoxide diffusing capacity in the early detection of major bleomycin-induced pulmonary toxicity.
Bell MR; Meredith DJ; Gill PG
Aust N Z J Med; 1985 Apr; 15(2):235-40. PubMed ID: 2411250
[TBL] [Abstract][Full Text] [Related]
15. Influence of platinum-induced renal toxicity on bleomycin-induced pulmonary toxicity in patients with disseminated testicular carcinoma.
van Barneveld PW; Sleijfer DT; van der Mark TW; Mulder NH; Donker AJ; Meijer S; Schraffordt Koops H; Sluiter HJ; Peset R
Oncology; 1984; 41(1):4-7. PubMed ID: 6199706
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of lung ventilation and carbon monoxide-diffusing capacity in patients with nonseminomatous testicular tumors treated with bleomycin.
Pagnoni A; Riboldi G; Valagussa P
Tumori; 1982 Feb; 68(1):85-9. PubMed ID: 6176056
[TBL] [Abstract][Full Text] [Related]
17. Membrane diffusion- and capillary blood volume measurements are not useful as screening tools for pulmonary arterial hypertension in systemic sclerosis: a case control study.
Overbeek MJ; Groepenhoff H; Voskuyl AE; Smit EF; Peeters JW; Vonk-Noordegraaf A; Spreeuwenberg MD; Dijkmans BC; Boonstra A
Respir Res; 2008 Oct; 9(1):68. PubMed ID: 18828919
[TBL] [Abstract][Full Text] [Related]
18. [Change of pulmonary diffusing capacity, membrane diffusing capacity and pulmonary capillary blood volume in patients with COPD and connective tissue disease at rest and post-exercise].
Chi L; Liu Y; Piao Z
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jun; 21(6):344-7. PubMed ID: 11326890
[TBL] [Abstract][Full Text] [Related]
19. [Letter: Consistency of alteration of alveolo-capillary transfer in man, due to an anti-tumor agent (bleomycin)].
Homasson JP; Boissinot E; Roullier A; Moline J
Nouv Presse Med; 1974 Apr; 3(17):1103. PubMed ID: 4135576
[No Abstract] [Full Text] [Related]
20. Pulmonary function assessment during bleomycin therapy.
Lampert-Benignus E; Eichler-Reiss F; Meunier-Carius J; Keiling R
Biomed Pharmacother; 1985; 39(2):87-93. PubMed ID: 2410052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
